newsfeed-en
@eurocrowd
17. Feb 2022 via Twitter
If you're a public authority and want to learn how #crowdfunding can help create local citizen finance schemes, join us tomorrow and hear the example of @RegeaAgency and their involvement in Citizens Finance Schemes: https://t.co/Tpr2enaocY— EUROCROWD (@eurocrowd) February 17, 2022
@eurocrowd
16. Feb 2022 via Twitter
🇮🇹 We're excited to let you know that we have established a local office in Italy as part of a wider framework agreement between EUROCROWD and @Arter_ER Emilia-Romagna Region’s Joint Stock Consortium and long-term member of EUROCROWD. Read more: https://t.co/tOgGqOaKgJ— EUROCROWD (@eurocrowd) February 16, 2022
@SachsAssociates
15. Feb 2022 via Twitter
e-Meet George Frodsham, Founder & CEO of @MediSieve at #Sachs_ELSFMore info @ https://t.co/b7zJA2j8ns#Sachs_ELSF #lifesciences #partnering #businessdevelopment #bd #licensing #health #investment #startup #healthcare #innovation #biotech #ehealth #business #invest #medicine pic.twitter.com/44jdJHuCbE— Sachs Associates (@SachsAssociates) Fe…
@eurocrowd
14. Feb 2022 via Twitter
Join us on Feb 18 and hear how pubic authorities can proactively involve citizens in #publicfunding decisions and co-investing and how #crowdfunding can help create local citizen finance schemes 👉 Register: https://t.co/Tpr2enaocY@RegeaAgency @CitizEE_project— EUROCROWD (@eurocrowd) February 14, 2022
@eurocrowd
14. Feb 2022 via Twitter
Do you find applying for #ECSP authorisation process unclear and complicated? Our Feb 16 webinar aims to help all EU #crowdfunding platforms with knowledge and expertise from our guests - this time, we will be joined by @upiattelli from @OsborneClarke: https://t.co/qpO7fsbBto pic.twitter.com/mHIpVmopfl— EUROCROWD (@eurocrowd) February 14, 202…
@eurocrowd
11. Feb 2022 via Twitter
For those of you who missed our first @CrowdTuesday this year where we talked about the ways #crowdfunding can be of help to #football stadiums and #sports buildings in their path towards #energyeffiency, you can find the recording on our YouTube channel: https://t.co/dMushasLBf pic.twitter.com/x6tG5G8hAE— EUROCROWD (@eurocrowd) February 11, …
@SachsAssociates
11. Feb 2022 via Twitter
e-Meet Kurt at #Sachs_ELSFMore info @ https://t.co/b7zJA2j8ns#Sachs_ELSF #lifesciences #partnering #businessdevelopment #bd #licensing #health #investment #startup #healthcare #innovation #biotech #ehealth #business #invest #medicine #venturecapital #pharma pic.twitter.com/V6GtB5pRfI— Sachs Associates (@SachsAssociates) February 11, 2022
@eurocrowd
10. Feb 2022 via Twitter
The second webinar on #ECSP is coming up on Feb 16! This time, will take a closer look at applying for the ECSP authorization, with the help of @upiattelli from @OsborneClarke. To learn more about how you can access the webinar, visit our website: https://t.co/qpO7fsbBto pic.twitter.com/IlaUiKUE37— EUROCROWD (@eurocrowd) February 10, 2022
@SachsAssociates
7. Feb 2022 via Twitter
Mestag was founded in 2020 to develop impactful therapies for patients by targeting activated fibroblast populations and their role in influencing the immune system in disease. e-Meet @Mestagtx at #Sachs_ELSFMore info @ https://t.co/b7zJA2j8ns pic.twitter.com/XXAFGmHC7y— Sachs Associates (@SachsAssociates) February 7, 2022
@eurocrowd
4. Feb 2022 via Twitter
#Football stadiums and sports buildings are among the main #energy consumers in Europe but #crowdfunding has proven to be a great tool for supporting #energyefficiency projects. @CrowdTuesday on Feb 8 has answers: https://t.co/kKjddAE6H1@hrovers @AndreaKollmann @greenfoot2020 pic.twitter.com/alf7lyQWwd— EUROCROWD (@eurocrowd) February 4, 2022…